01 15Nexium
02 1Vimovo
Main Therapeutic Indication : Gastrointestinal Disorders
Currency : USD
2020 Revenue in Millions : 717
2019 Revenue in Millions : 729
Growth (%) : -2
Main Therapeutic Indication : Gastrointestinal Disorders
Currency : USD
2020 Revenue in Millions : 1,492
2019 Revenue in Millions : 1,483
Growth (%) : 1
Main Therapeutic Indication : Gastrointestinal Disorders
Currency : USD
2021 Revenue in Millions : 478
2020 Revenue in Millions : 713
Growth (%) : -28
Main Therapeutic Indication : Gastrointestinal Disorders
Currency : USD
2021 Revenue in Millions : 1,326
2020 Revenue in Millions : 1,492
Growth (%) : -11